The Sunrise of Tertiary Lymphoid Structures in Cancer. [PDF]
ABSTRACTFirst considered as a negative epiphenomenon in autoimmune and inflammatory diseases, with possible deleterious consequences through the production of pathological autoantibodies and antiself T cells, tertiary lymphoid structures (TLS) have gained major scientific and clinical interest in cancer due to their association with better clinical ...
Rochefort J +3 more
europepmc +3 more sources
Comparative Analysis of Pathology Foundation Models for Automated Detection of Tertiary Lymphoid Structures in Hematoxylin-and-Eosin-Stained Digital Pathology Images. [PDF]
Guan M +9 more
europepmc +1 more source
Application of quantitative imaging parameters combined with tertiary lymphoid structures in recurrence risk assessment of soft tissue sarcoma: a retrospective study. [PDF]
Yi Y +5 more
europepmc +1 more source
FOXP3<sup>+</sup> Cells in Tertiary Lymphoid Structures Have Adverse Impact on Overall Survival in Patients with Gastric Cancer. [PDF]
Paparella Karaman A +6 more
europepmc +1 more source
Beyond Surgical Margins: Fully Mature Tertiary Lymphoid Structures (fmTLSs) Are Predictive Biomarkers for Local Recurrence in Primary Soft-Tissue Sarcomas. [PDF]
Michot A +12 more
europepmc +1 more source
Tertiary lymphoid structures in renal cell carcinoma: from heterogeneity dissection to translational precision immunotherapy. [PDF]
Li Z, Ruan S, Yu Y, Xiang H, Mi W.
europepmc +1 more source
Integrating tertiary lymphoid structures and microvascular invasion to refine postoperative prognostic stratification in hepatocellular carcinoma. [PDF]
Gan K, Gao F.
europepmc +1 more source
Comprehensive analysis based on tertiary lymphoid structures and tumor budding predicts survival rates in colorectal cancer patients with synchronous liver metastases. [PDF]
Zhang J +8 more
europepmc +1 more source
Mature tertiary lymphoid structures tumor microenvironment-based risk model to assess patients with pancreatic ductal adenocarcinoma. [PDF]
Gu Z, He C, Cheng S, Su Q, Yu J.
europepmc +1 more source

